DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Taxonomy: TH- Response Assessment: General (most aspects)
| PO-GePV-T-117 | Tumor Control Probability for Stereotactic Body Radiotherapy of Early Stage Hepatocellular Carcinoma F Liu*, M Munley, Wake Forest University School of Medicine, Winston-salem, NC |
| PO-GePV-T-118 | Sparing Salivary Function Following Submandibular Gland Transfer in Head and Neck Cancer Patients: Preliminary Results of a Prospective Trial V Moiseenko*, T Atwood, C Coffey, L Blumenfeld, P Hua, B Tuma-Marcella, P Sanghvi, UC San Diego, La Jolla, CA |
| PO-GePV-T-119 | Pattern of Treatment and Outcome for Esophageal Adenocarcinoma in the United States: Longitudinal Analysis of a Large Hospital Based Registry A Dey1, T Biswas2, T Podder2*, (1) University of Akron, Akron, OH, (2) University Hospitals Seidman Cancer Center, Cleveland, OH |
| TU-AB-BRC-0 | Biomarkers of Response to Radiation and Immune Modulating Therapies for Advanced Cancer Management D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-1 | Introduction to the Biomarker Landscape D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-2 | Evolving Paradigm for Assessing Response to Immunomodulatory Therapies D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-3 | Radiomics of Radiation and Immune Response Patterns D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-4 | Clinical and Preclinical Imaging of the Immune System D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-5 | Role of Molecular Diagnostics and Advanced Tumor Tissue Analysis To Guide Optimal Anti-Cancer Treatment D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-6 | Combining Imaging & Circulating Biomarkers of Response To Personalize Chemo-Immunotherapy and Radiation Therapy D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-AB-BRC-7 | Panel Discussion D Mankoff1*, M Farwell1*, R Li2*, A Wu3*, K Schalper4*, S Bowen5*, (1) University of Pennsylvania, Philadelphia, PA, (2) Stanford University, Palo Alto, CA, (3) City of Hope, Los Angeles, CA, (4) Yale University, New Haven, CT, (5) University of Washington, School of Medicine, Issaquah, WA |
| TU-D930-IePD-F6-3 | COVID-19 Pandemic Induced Practice Changes in the Study of The American Association of Physicists in Medicine (AAPM) Northern California Chapter X Liu1*, J Zhang2, A Yu3, V Sehgal4, X Qi5, D Ruan6, M Barker7, Z Shen8, S Goetsch9, (1) Kaiser Permanente, Los Angeles, CA, (2) USC Keck School Of Medicine, Los Angeles, CA,(3) Stanford University Cancer Center, Stanford, CA, (4) University Of California, Irvine, Orange, CA, (5) UCLA School of Medicine, Los Angeles, CA, (6) UCLA School of Medicine, Los Angeles, CA, (7) Sansum Clinic, Santa Barbara, CA, (8) University of Southern California, Los Angeles, CA, (9) San Diego Medical Physics, Solana Beach, CA |
| WE-C1000-IePD-F7-2 | Hypofractionated Radiotherapy Regimens for Early Stage Non-Small Cell Lung Cancer F Liu*, M Munley, Wake Forest University School of Medicine, Winston-salem, NC |